Ledger.Open graph →
SEC Form D · filed June 23, 2020

Oisin Biotechnologies, Inc

Offering
$5.0M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

David Gobel · Seattle, WADirectorEric Garcia · Seattle, WAExecStephen Jouzapaitis · Chicago, ILDirectorSteve Hilbert · Seattle, WAExecJoseph Gits · Chicago, ILExec · DirectorSteve Hilbert · Seattle, WAExecJohn Lewis · Edmonton, Alberta, CanadaExecChad Eisenberg · Chicago, ILExec · DirectorJohn Lewis · Cayman Islands, Cayman IslandsExecRebeca Minguela · Madrid, U3Exec · DirectorCasey Gard · Bal Harbour, FLExec · DirectorEric Garcia · San Francisco, CAExecMatthew Scholz · Seattle, WAExec · DirectorArena Capital Advisors LLC Arena Capital Advisors Arena Capital Advisors LLC · Los Angelea, CADirectorJohn Lewis · Grand Cayman, Cayman IslandsExecGary Hudson · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗